Sacubitril and Valsartan
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
71610-955 -
Package NDC
71610-955-19 -
Application number
ANDA213748 -
SPL ID
4134b078-47c2-9e82-e063-6294a90aaaee -
SPL set ID
4134afd2-a0a0-a64a-e063-6394a90ae580 -
UNII
17ERJ0MKGI -
UNII
80M03YXJ7I -
RxCUI
1656354
What the source publishes
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Active ingredients
- Sacubitril and Valsartan
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Sacubitril and Valsartan",
"splId": "4134b078-47c2-9e82-e063-6294a90aaaee",
"labels": [
{
"setId": "4134afd2-a0a0-a64a-e063-6394a90ae580",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4134afd2-a0a0-a64a-e063-6394a90ae580",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4134afd2-a0a0-a64a-e063-6394a90ae580"
}
],
"routes": [
"ORAL"
],
"labeler": "Aphena Pharma Solutions - Tennessee, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "3060 TABLET, FILM COATED in 1 BOTTLE (71610-955-19)",
"package_ndc": "71610-955-19",
"identifierStatus": "well-formed",
"marketing_start_date": "20251014"
}
],
"productId": "71610-955_4134b078-47c2-9e82-e063-6294a90aaaee",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "71610-955",
"deaSchedule": null,
"genericName": "Sacubitril and Valsartan",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "SACUBITRIL",
"strength": "97 mg/1"
},
{
"name": "VALSARTAN",
"strength": "103 mg/1"
}
],
"applicationNumber": "ANDA213748",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20250121",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000070",
"N0000175561"
],
"unii": [
"17ERJ0MKGI",
"80M03YXJ7I"
],
"rxcui": [
"1656354"
],
"spl_set_id": [
"4134afd2-a0a0-a64a-e063-6394a90ae580"
],
"pharm_class_epc": [
"Angiotensin 2 Receptor Blocker [EPC]"
],
"pharm_class_moa": [
"Angiotensin 2 Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"Aphena Pharma Solutions - Tennessee, LLC"
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:71610-955_4134b078-47c2-9e82-e063-6294a90aaaee"